Logo of Wide Open Agriculture (ASX:WOA)Latest Wide Open Agriculture (ASX:WOA) News

Page 1
Page 1 of 3

WOA adds three Asian manufacturers as lupin scale-up enters feasibility phase

Wide Open Agriculture has signed three additional non-binding framework agreements with prospective contract manufacturers in Vietnam, India and Indonesia, bringing its shortlist to four. The agreements protect WOA’s lupin intellectual property while technical and commercial feasibility work begins, but stop well short of securing production or revenue.
Victor Sage
14 Sept 2026

Wide Open Agriculture narrows loss, shifts to contract manufacturing model, advances lupin ingredient commercialization

Wide Open Agriculture cut its loss to $3.64 million in FY2026 as it pivots from owning manufacturing to a capital-light contract model, while securing global commercial traction for its lupin-based ingredients.
Ada Torres
31 Aug 2026

WOA Advances Lupin Production with Proeon Framework Agreement

Wide Open Agriculture (ASX: WOA) has taken a significant step towards a capital-light production model by signing a non-binding framework agreement with Proeon Foods for contract manufacturing of its lupin-based ingredients, including exclusive Indian distribution rights.
Ada Torres
10 Aug 2026

WOA Advances Contract Manufacturing Shift, Winds Down German Facility

Wide Open Agriculture (ASX: WOA) is executing a major strategic pivot by closing its German production site and transitioning to a capital-light contract manufacturing model to improve economics and scale lupin protein production.
Ada Torres
28 July 2026

WOA Shifts to Contract Manufacturing, Winds Down German Facility to Boost Lupin Scale-Up

Wide Open Agriculture is closing its German plant and pivoting to contract manufacturing in Asia to cut costs and scale lupin ingredient production efficiently under new CEO Craig Swan.
Ada Torres
2 July 2026

WOA Simplifies Royalty to Boost Lupin Protein Scale-Up

Wide Open Agriculture has agreed with Curtin University to replace its tiered royalty structure with a single 3.5% flat royalty on net sales, streamlining financial planning and enhancing commercial scalability for its lupin protein technology.
Ada Torres
25 May 2026

Wide Open Agriculture Shifts to Capital Light Lupin Production Under New CEO

Wide Open Agriculture appoints Craig Swan as CEO and pivots to a contract manufacturing model to improve economics and scale lupin protein production, while receiving a A$1.69 million R&D tax rebate.
Ada Torres
23 Apr 2026

Wide Open Agriculture Secures A$1.69M R&D Tax Rebate to Boost Lupin Protein Commercialisation

Wide Open Agriculture Ltd (ASX: WOA) has received a A$1,686,579 R&D tax rebate for the 2024-25 financial year, reflecting its significant innovation efforts in lupin protein development across Australia and Germany. The rebate will support the company’s commercialisation and growth initiatives.
Ada Torres
9 Apr 2026

Wide Open Agriculture Taps Craig Swan to Accelerate Lupin Protein Growth

Wide Open Agriculture has appointed Craig Swan as its new CEO, signaling a strategic push to commercialise its lupin protein technology and expand its footprint in Asia.
Eva Park
3 Mar 2026

Wide Open Agriculture Advances Lupin Protein Scale-Up and China Market Entry

Wide Open Agriculture has made significant strides in expanding its intellectual property and commercial footprint, including a new patent for lupin protein milk and first sales of lupin oil, while progressing plans for a large-scale manufacturing facility in Western Australia.
Ada Torres
30 Jan 2026

Wide Open Agriculture Revamps Board, Eyes Global Scale-Up with New CEO Search

Wide Open Agriculture shakes up its leadership with a new board appointment and plans to recruit a CEO experienced in scaling plant protein businesses, signaling a strategic push to globalise its lupin protein technology.
Eva Park
1 Dec 2025

Wide Open Agriculture Secures $586k R&D Rebate for German Innovation

Wide Open Agriculture has received a $586,624 tax rebate for its overseas research activities in Germany, supporting the commercialisation of its proprietary lupin protein products.
Eva Park
24 Nov 2025